Location: Addis Ababa, Ethiopia
Organization: Amref Health Africa
Deadline: July 21, 2025
1. About Amref Health Africa:
Amref Health Africa is the largest African-based and led international health development organization serving over 30 million people annually across 35 countries in sub-Saharan Africa. Strategically engaging with communities, governments, and local partners for the past 65 years, we work through our European and North American network of sister organizations on program implementation, advocacy, fundraising and partnership. Our subsidiaries include Amref Flying Doctors, Amref Enterprises Limited, and the Amref International University.
Our organization is driven by its vision to bring lasting health change in Africa and its mission to catalyze and drive community-led and people-centered health systems while addressing social determinants of health. Amref believes that the power to transform Africa’s health lies within its communities and therefore strives to ensure that health systems are functioning at an optimal level and communities are empowered to hold these systems accountable for the delivery of high-quality and affordable health care.
Amref has been active in Ethiopia since the 1960s and became fully operational as of 2002. We have been partnering with the Ethiopian government and local communities to co-create solutions and implement diverse health and development project portfolios throughout the country for over twenty years. Aligning with the national Health Sector Transformation Plan II (HSTP II), we work to ensure health equity by serving women and children, reaching the most disadvantaged, inaccessible communities including pastoralist communities and placing an emphasis on youth development.
Our programs are designed to support community level interventions while strengthening health systems at the regional and national levels. With an integrated and multi-sectoral approach, Amref strategically addresses cross-cutting issues through these programmatic focus areas. For more information, visit our website www.amref.org.
Background:
In Ethiopia, vaccine preventable diseases are contributing substantially to under-five mortality. Measles is one of the leading causes of under-five mortality. Despite this progress, including the expansion of routine immunization services from six to twelve antigens, gaps remain in health worker training and resource allocation. Ethiopia has over a million under-immunized children and HPV vaccination rates for girls are limited.
In 2018, only 79% of planned immunization sessions were conducted, with outreach and mobile sessions falling to 19% and 10%, respectively. Community and Health system challenges, including limited human resources and inadequate infrastructures to maintain the cold chain and vaccine supply, contribute to zero dose and under immunization in developing countries1. In Ethiopia, studies have identified several barriers, such as limited human resource capacity, increased workload among health workers, and lengthy waiting periods at health facilities. Planning issues and inaccurate population denominators further hinder vaccination efforts.1 Furthermore, as country the introduction of currently emerging novel vaccines such as COVID-19, IPV2, Rotasil, malaria, and Hep B birth dosage needs high level technical and coordination skill.
The Saving lives and livelihood phase 1 implementation of the program has revealed both successes and challenges that provide valuable learning opportunities. Key successes include the successful integration of the program, effective execution of national-level COVID-19 vaccination campaigns, and ongoing routine immunization efforts. However, critical challenges have emerged, particularly related to budget and operational disruptions, such as sudden budget cuts and project pauses that pose significant risks. These disruptions highlight the need for improved financial management to ensure program continuity, enhanced operational resilience through flexible financial planning, and the importance of transparent stakeholder communication during financial uncertainties.
Additionally, challenges in technical assistance management have been noted. Key learning areas identified include the establishment of clearer communication protocols with donors, the development of robust guidance mechanisms, and the creation of flexible implementation frameworks, along with improved communication with ACDC, HQ and the Mastercard Foundation. Recommended actions encompass the development of comprehensive communication strategies, detailed contingency plans, regular donor check-ins, and adaptive project management approaches. Strategic recommendations further suggest implementing flexible budgeting models, comprehensive risk management strategies, enhanced stakeholder engagement, and transparent reporting mechanisms.
Overall, this experience underscores the critical importance of adaptability, clear communication, and strategic planning in navigating complex immunization programs Phase II of the Saving Lives and Livelihoods Programmes will primarily focus on strengthening countries ability to respond to future pandemics through programmatic activities designed to build and protect the health workforce, as well as improving the lives and livelihoods of the population.
Supporting the preparation of a national immunization strategy that encompasses a life-course approach and the introduction of new vaccines is crucial for enhancing pandemic preparedness. This strategy ensures that immunization programs are not just reactive but proactive, addressing the health needs of individuals at various life stages—from infancy through adulthood. By integrating new vaccines into the existing immunization framework, we can safeguard populations against emerging infectious diseases and reduce vulnerability during public health emergencies. In addition to developing a comprehensive immunization strategy, building health workforce capacity is essential.
A well-trained and adequately staffed health workforce is vital for effective vaccine delivery, public health communication, and community engagement. This capacity-building effort includes training healthcare professionals on the latest immunization practices, ensuring they are equipped to handle both routine immunizations and emergency responses during pandemics.
1.2 Justification
Operational Focus: The aims to optimize vaccination programs through a human-centered design approach. The focus is on enhancing the performance of existing vaccination systems—rather than creating new products—through operational research that improves service delivery, workflow efficiency, and user engagement.
HCD Integration: Human-Centered Design (HCD) offers a structured, user-driven process that integrates stakeholder insights at every stage. HCD phases Empathize, Define, Ideate, Prototype, and Test allow researchers to align service improvements with actual user experiences and system constraints.
Target Population Specificity: The study targets multiple age groups, enabling comparison of experiences and barriers across demographics such as children, caregivers, adolescents, and elderly adults. This segmentation allows for the design of tailored interventions based on the specific needs of each group.
2. Objectives
General Objective: To optimize vaccination service delivery by identifying and addressing barriers using Human-Centered Design (HCD) methodology.
Specific Objectives:
3. Methodology
The selected consultant will be expected to lead the full Human-Centered Design (HCD) process and deliver scientifically sound and contextually relevant results. The proposed methodology should align with the objectives of optimizing vaccination service delivery, while being rigorous enough to inform programmatic decisions and contribute to peer-reviewed publications.
Amref encourages the consultant to propose an innovative, yet practical mixed-method research approach, incorporating both qualitative and quantitative tools. The methodology should include a clear sampling strategy, robust data collection methods, quality assurance mechanisms, and capacity-building components. In particular, the consultant will also be responsible for capacitating Amref staff who will be part of the HCD core team, ensuring long-term sustainability of the approach.
The methodology must include a complete lifecycle of HCD phases as described below:
Phase 1: Empathize (Qualitative)
Phase 2: Define
Phase 3: Ideate
Phase 4: Prototype
Phase 5: Test and Refine
Consultant’s Additional Responsibilities within the Methodology
4. Target Population
This broad participant group ensures a 360-degree understanding of vaccine uptake challenges across the lifecycle and across service levels.
5. Expected Deliverables
Anticipated Impact: Ultimately, the aim is a more effective, responsive, and equitable vaccination program that meets people where they are.
Total Duration: Approximately 15 weeks
| Phase | Duration |
| Empathize | 2 weeks |
| Define | 2 week |
| Ideate | 1 week |
| Training and prototype | 6 weeks |
| Test & refine/coaching | 2 weeks |
| Monitoring and Reporting | 2weeks on wards |
Specific tasks to be done by the consultant
8. Period for Submission and deliverables
Bids will be evaluated based on the below criteria.
Bids lacking any of the documents below will be considered as non-responsive and therefore will be eliminated at this stage.
| No. | Particulars | Marks | Compliant | Non-compliant |
| 1. | Provide a copy Valid License | 1 or 0 | ||
| 2. | Provide a copy of Valid TIN/Tax Compliance Certificate | 1 or 0 | ||
| 3. | Provide a copy of VAT certificate | 1 or 0
|
Note: Bids missing any of the 3 mandatory requirements above will be considered as non-responsive bid and therefore will be eliminated at this stage.
1. Technical evaluation criteria
| Title of the task | Technical proposal to ………………….. | ||||
| Name of consultant | |||||
| Dimensions | Description | Wt | Score | Remark | |
|
1 | Methods used (54) | Description of local area contexts and population- relating to the study nature | 4 | ||
| Clarity of the study population description- How specifically explained | 4 | ||||
Determined justifiable sampling procedure and sample size
| 16 | ||||
| Stated appropriate and relevant data collection methods as per the ToR- Does the consultant include and show clue for the tools | 10 | ||||
Appropriateness of data analysis methods planned
| 5 | ||||
Clarity of Methods used to address objectives
| 15 | ||||
|
2 | Team composition (4)
| 5 or more professional team relevant to the work done | 4 | ||
| 4 or more professional team relevant to the work done | 3 | ||||
| 3 or more professional team relevant to the work done | 2 | ||||
| 2 or more professional team relevant to the work done | 1 | ||||
| 1 or more professional team relevant to the work done | 0 | ||||
|
3 | Experience (6)
| At least 5 and more relevant attached experience | 6 | ||
| 4 relevant attached experience | 4 | ||||
| 3 relevant attached experience | 3 | ||||
| 2 relevant experience | 2 | ||||
| 1 relevant experience | 1 | ||||
| None (0) and records of unsuccessful assignment | 0 | ||||
| 4 | Work schedule (3) | Work schedule was prepared as Per the ToR | 3 | ||
| 5 | Overall structure of the proposal(3) | Please give rate the maximum three to the lowest -0: as general summary | 3 | ||
| Total Score =(70) | 70 | ||||
2. The Financial Proposal
This should be an outline and is indicative only at this stage. Bidders are requested to develop a more detailed budget proposal as part of the final stage of the process.
| Description | Amount in ETB |
| Financial Quotation – Indicative budget to accomplish the task (Detailed cost proposal in ETB for the consultancy) | |
| All Applicable Taxes | |
| Total Amount in ETB |
Target Population
Eligibility Requirements and Technical Specifications
Any interested bidder, shall provide, in its submission in response to this TOR, sufficient documentary evidence of adherence to the eligibility and minimum qualification criteria detailed below. Amref Health Africa will assess the documents submitted by the applicants in response to this TOR;
Amref Health Africa, Ethiopia Office invites bids from eligible bidders for the provision of consultancy service Consultancy Service to Conduct Optimizing Vaccination Programs Through Human-Centered Design: Targeting Coverage Gaps Across Age Groups
1. All firms organized and licensed under the laws of Ethiopia that qualify to bid are invited to participate in this bid and have to fulfill the following requirements
a. Bidders should have a valid and renewed trade license for the year;
b. Bidders should be VAT registered
c. bidders should have TIN certificate
2. Bidders must submit their technical , financial offer and legal documents separately in soft copy only marked as technical, financial document and legal document at: Tender.Ethiopia@amref.org on or before July 21st -2025- before close of business @5:00pm.
The financial bid will only be opened for those bidders who will have qualified in the technical evaluation.
Tender Documents should be received on or before July 21st -2025 – 5:00p.m. at Tender.Ethiopia@amref.org Late tenders will be rejected.
The aforementioned Office reserves the right to accept or reject any or all bids and is not bound to give reasons for its decision.
N.B. BIDDERS SHOULD CLEARLY STATE THE E-MAIL SUBJECT: “OPTIMIZING VACCINATIN PROGRAMS”.
BIDDERS WHO WILL NOT CLEARLY STATE THE SUBJECT WILL NOT BE CONSIDERED FOR THE EVALUATION
Location: Addis Ababa, Ethiopia Organization: Save the Children International Closing Date: June 27, 2026, 07:53 AM…
Location: Yebelo, Oromia, Ethiopia Deadline: Jun 25, 2026 Job Description Our Profile People in Need is a…
Location: Global/Multiple Organization: Life & Peace Institute (LPI) Deadline: July 3, 2026 Job Description The Life…
Deadline: varies | Location: Addis Ababa, Ethiopia
Deadline: June 25, 2026 | Location: Addis Ababa, Ethiopia
Deadline: July 3, 2026 | Location: Global/Multiple